Company performance
Add to research
Current Price
as of Jul 10, 2025$29.64
P/E Ratio
64.05
Market Cap
$47.21B
Description
Add to research
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Metrics
Add to research
Overview
- HQOsaka, OS
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- Ticker4502
- Price$29.636414-1.86%
Trading Information
- Market cap$47.21B
- Float96.17%
- Average Daily Volume (1m)3,519,143
- Average Daily Volume (3m)3,951,974
- EPS$68.36
Company
- Revenue$4.58T
- Rev growth (1yr)7.45%
- Net income$107.93B
- Gross margin53.59%
- EBITDA margin30.32%
- EBITDA$1.39T
- EV$11.79T
- EV/Revenue2.57
- P/E64.05
- P/S1.53
- P/B0.99
- Debt/Equity73.37
Documents
Add to research
Factset Street Account
Wikipedia